Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (31-40 of 167) with videos related to

Pageof 17
Sort By:
Plos One|October 1, 2020
REV-ERB agonism improves liver pathology in a mouse model of NASHKristine Griffett, Gonzalo Bedia-Diaz, Bahaa Elgendy, et al.
ACS Chemical Neuroscience|December 2, 2015
Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of AutismYongjun Wang, Cyrielle Billon, John K Walker, et al.
ACS Pharmacology & Translational Science|November 8, 2019
Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver DiseaseMonideepa Sengupta, Kristine Griffett, Colin A Flaveny, et al.
ACS Chemical Biology|November 4, 2010
Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERBDouglas Kojetin, Yongjun Wang, Theodore M Kamenecka, et al.
The Journal of Biological Chemistry|September 7, 2010
Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target geneChristine Crumbley, Yongjun Wang, Douglas J Kojetin, et al.
The Journal of Biological Chemistry|December 26, 2001
Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1Yifei Wu, Philippe Delerive, William W Chin, et al.
The Journal of Biological Chemistry|December 28, 2002
Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gammaYifei Wu, William W Chin, Yong Wang, et al.
The Journal of Biological Chemistry|November 21, 2018
RORγ regulates the NLRP3 inflammasomeCyrielle Billon, Meghan H Murray, Amer Avdagic, et al.
Vitamins and Hormones|June 15, 2004
Pharmacology of nuclear receptor-coregulator recognitionRajesh S Savkur, Kelli S Bramlett, David Clawson, et al.
Drug Discovery Today|October 16, 2007
Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulatorsClaus Kremoser, Michael Albers, Thomas P Burris, et al.
Pageof 17

Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Plos One|October 1, 2020
REV-ERB agonism improves liver pathology in a mouse model of NASHKristine Griffett, Gonzalo Bedia-Diaz, Bahaa Elgendy, et al.
ACS Chemical Neuroscience|December 2, 2015
Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of AutismYongjun Wang, Cyrielle Billon, John K Walker, et al.
ACS Pharmacology & Translational Science|November 8, 2019
Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver DiseaseMonideepa Sengupta, Kristine Griffett, Colin A Flaveny, et al.
ACS Chemical Biology|November 4, 2010
Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERBDouglas Kojetin, Yongjun Wang, Theodore M Kamenecka, et al.
The Journal of Biological Chemistry|September 7, 2010
Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target geneChristine Crumbley, Yongjun Wang, Douglas J Kojetin, et al.
The Journal of Biological Chemistry|December 26, 2001
Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1Yifei Wu, Philippe Delerive, William W Chin, et al.
The Journal of Biological Chemistry|December 28, 2002
Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gammaYifei Wu, William W Chin, Yong Wang, et al.
The Journal of Biological Chemistry|November 21, 2018
RORγ regulates the NLRP3 inflammasomeCyrielle Billon, Meghan H Murray, Amer Avdagic, et al.
Vitamins and Hormones|June 15, 2004
Pharmacology of nuclear receptor-coregulator recognitionRajesh S Savkur, Kelli S Bramlett, David Clawson, et al.
Drug Discovery Today|October 16, 2007
Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulatorsClaus Kremoser, Michael Albers, Thomas P Burris, et al.
Pageof 17